Table 1. Patient characteristics.
| Characteristic | Patients | SULF2 | ||
| N = 100, N (%) | SULF2M | SULF2U | P Value | |
| Age | ||||
| >62 | 52 (52%) | 14 | 38 | 0.83 |
| ≤62 | 48 (48%) | 14 | 34 | |
| Sex | ||||
| Male | 73 (73%) | 21 | 52 | 0.49 |
| Female | 27 (27%) | 7 | 20 | |
| Histology | ||||
| Adenocarcinoma | 79 (79%) | 24 | 55 | 0.59 |
| Mucinous | 11 (11%) | 2 | 9 | |
| Signet ring cell | 10 (10%) | 2 | 8 | |
| Tumor Site | ||||
| Distal | 35 (35%) | 6 | 29 | 0.21 |
| Proximal | 38 (38%) | 13 | 25 | |
| Whole stomach | 27 (27%) | 9 | 18 | |
| Stage | ||||
| I,II | 37 (37%) | 8 | 29 | 0.36 |
| III, IV | 63 (63%) | 20 | 43 | |
| Histological grade | ||||
| 2 | 27 (27%) | 5 | 22 | 0.23 |
| 3 | 44 (44%) | 16 | 28 | |
| Mixed 2–3 | 29 (29%) | 7 | 22 | |
| Lymph node metastasis | ||||
| No | 25 (25%) | 5 | 20 | 0.44 |
| Yes | 75 (75%) | 23 | 52 | |